During this time of uncertainty, Sanofi wants people living with diabetes to know that we are here to help you access your Sanofi medicines.

By Gustavo Pesquin, Head of North America General Medicines

Every day we have the privilege of working to support people living with diabetes and their healthcare providers. Our portfolio of medicines and services are a constant for those who live and manage this chronic condition. And we know that access to our medicines are paramount to the health and wellbeing of those we serve. While we are constantly innovating and listening to patient feedback, our ability to ensure patient access to our medicines is always at the forefront, and especially during this unprecedented time with the COVID-19 pandemic.

I want reassure people living with diabetes that Sanofi remains committed to offering innovative programs to access our medicines.

First, I’m sure some people living with diabetes may be concerned about getting their Sanofi medicines at the pharmacy. At this time, Sanofi does not anticipate shortages for patients resulting from the COVID-19 situation. I’m proud of the global network of manufacturing plants that we have that are up-and-running, and I am humbled by our employees’ commitment to delivering our medicines to patients worldwide.

If you find that your local pharmacy is temporarily out of your Sanofi medicine – likely a result of some people picking up their medicines earlier than normal due to local restrictions – your pharmacy can order additional medicine from their wholesaler usually within 24 business hours. I encourage people in this situation to speak with their local pharmacies since Sanofi does not have any products on manufacturer backorder due to COVID-19.

We also have a responsibility to address the needs of patients who are concerned about affording their medicines during an unexpected financial situation, such as the one many are facing as a result of COVID-19. In fact, we are prepared for moments like this as a result of launching programs that work within the current system to help improve access and affordability of our insulins.

Commercially Insured

100% of commercially insured patients are eligible for co-pay assistance programs, regardless of income or insurance plan design, which limits out-of-pocket expenses for a majority of patients to $0 or $10. 


100% of uninsured patients are eligible for the Insulins Valyou Savings Program – regardless of income level – enabling them to buy one or multiple Sanofi insulins* for a fixed price of $99 per month, for up to ten boxes of pens and/or 10 mL vials. 

Qualified Low- and Middle-Income

Free medications are available to qualified low- and middle-income patients through the patient assistance component of the Sanofi Patient Connection program. Some people who have lost insurance due to a change in employment status from COVID-19 may qualify to receive free medicine through this program.

Every patient has unique circumstances, so there is not a one size fits all solution. We urge all people living with diabetes taking Sanofi products who are facing financial hardship, especially those who may have been financially impacted by the COVID-19 pandemic, to call us. Sanofi has live support specialists at (855) 984-6302 to answer each patient’s questions and navigate their individual situations to find the best resources and programs to help lower their out-of-pocket costs.

I understand this is a challenging time and people are learning how to manage a new way of living. I hope this message can bring some comfort that Sanofi is here to help people living with diabetes get through this.

* The Insulins Valyou Savings Program does not include Sanofi's combination insulin product.